Author:
Walton M. J.,O’Connor J.,Carroll C.,Claxton L.,Hodgson R.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Health Policy,Pharmacology
Reference13 articles.
1. National Institute for Health and Care Excellence. Guide to the processes of technology appraisal. NICE. 2018.
https://www.nice.org.uk/process/pmg19/chapter/acknowledgements
. Accessed 1 Jul 2018.
2. National Institute for Health and Care Excellence. Proposals for increasing capacity within NICE’s technology appraisal programme. NICE. 2017.
https://www.nice.org.uk/Media/Default/About/what-we-do/our-programmes/technology-appraisals/increasing-ta-capacity-consultation.pdf
. Accessed 21 Dec 2017.
3. Yan L, Zhang W. Precision medicine becomes reality—tumour type agnostic-therapy. Cancer Commun. 2018;38(6).
4. National Institute for Health and Care Excellence, NHS England. Consultation on changes to technology appraisals and highly specialised technologies. NHS England. 2017.
5. Carroll C, Houten R, Boland A, Kaltenthaler E, Dickson R. What is the evidence from past National Institute of Health and Care Excellence Single-Technology Appraisals regarding company submissions with base-case incremental cost-effectiveness ratios of less than £10,000/QALY? Value Health. 2017;21:341–50.
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献